Resona Asset Management Co. Ltd. Has $4.68 Million Stock Holdings in Omega Healthcare Investors, Inc. (NYSE:OHI)

Key Points

• Resona Asset Management Co. Ltd. increased its stake in Omega Healthcare Investors, Inc. by 14.3% in Q1, now holding $4.68 million worth of shares.
• The quarterly dividend recently declared amounts to $0.67, yielding 6.5%, with a payout ratio currently at 165.43%.
• Analysts have a consensus rating of "Hold" for Omega Healthcare Investors, with the average target price set at $42.00.

Resona Asset Management Co. Ltd. lifted its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report) by 14.3% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 122,845 shares of the real estate investment trust's stock after buying an additional 15,405 shares during the period. Resona Asset Management Co. Ltd.'s holdings in Omega Healthcare Investors were worth $4,678,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. NBC Securities Inc. acquired a new position in shares of Omega Healthcare Investors during the 1st quarter worth about $29,000. Dunhill Financial LLC boosted its stake in shares of Omega Healthcare Investors by 97.9% during the 4th quarter. Dunhill Financial LLC now owns 1,516 shares of the real estate investment trust's stock worth $57,000 after buying an additional 750 shares during the last quarter. CoreCap Advisors LLC boosted its stake in shares of Omega Healthcare Investors by 177.3% during the 4th quarter. CoreCap Advisors LLC now owns 1,578 shares of the real estate investment trust's stock worth $60,000 after buying an additional 1,009 shares during the last quarter. Park Square Financial Group LLC acquired a new position in shares of Omega Healthcare Investors during the 4th quarter worth about $61,000. Finally, UMB Bank n.a. lifted its stake in Omega Healthcare Investors by 94.9% in the 1st quarter. UMB Bank n.a. now owns 2,175 shares of the real estate investment trust's stock valued at $83,000 after purchasing an additional 1,059 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Omega Healthcare Investors news, Director Lisa Egbuonu-Davis sold 2,500 shares of the stock in a transaction dated Friday, August 8th. The shares were sold at an average price of $40.16, for a total value of $100,400.00. Following the transaction, the director directly owned 18,654 shares of the company's stock, valued at $749,144.64. This represents a 11.82% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. 1.50% of the stock is currently owned by corporate insiders.

Analyst Ratings Changes

OHI has been the subject of several recent analyst reports. Royal Bank Of Canada raised their target price on shares of Omega Healthcare Investors from $39.00 to $41.00 and gave the company a "sector perform" rating in a research note on Thursday, August 7th. Wells Fargo & Company upgraded shares of Omega Healthcare Investors from an "equal weight" rating to an "overweight" rating and raised their target price for the company from $38.00 to $41.00 in a research note on Monday, July 14th. Five research analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, the stock has an average rating of "Hold" and an average price target of $42.00.

Omega Healthcare Investors Stock Up 0.3%

Omega Healthcare Investors stock opened at $40.98 on Friday. The stock has a market cap of $12.09 billion, a P/E ratio of 25.30, a P/E/G ratio of 2.82 and a beta of 0.66. The company has a quick ratio of 7.10, a current ratio of 7.10 and a debt-to-equity ratio of 0.96. Omega Healthcare Investors, Inc. has a twelve month low of $35.04 and a twelve month high of $44.42. The company's 50-day moving average price is $38.03 and its two-hundred day moving average price is $37.45.

Omega Healthcare Investors (NYSE:OHI - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The real estate investment trust reported $0.77 earnings per share for the quarter, beating the consensus estimate of $0.45 by $0.32. The firm had revenue of $235.60 million for the quarter, compared to analysts' expectations of $248.49 million. Omega Healthcare Investors had a net margin of 42.23% and a return on equity of 9.78%. The business's revenue was up 11.8% on a year-over-year basis. During the same period in the prior year, the firm earned $0.71 EPS. As a group, analysts expect that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current year.

Omega Healthcare Investors Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Monday, August 4th were issued a $0.67 dividend. This represents a $2.68 annualized dividend and a yield of 6.5%. The ex-dividend date of this dividend was Monday, August 4th. Omega Healthcare Investors's dividend payout ratio is currently 165.43%.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.

Want to see what other hedge funds are holding OHI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Omega Healthcare Investors, Inc. (NYSE:OHI - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.